AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
RANBAXY SCOUTING FOR USFDA APPROVED PLANTS FOR ACQUISITION.
NEW DELHI, Nov 3 Asia Pulse - Pharmaceuticals company Ranbaxy Laboratory (BSE:500359) is looking for USFDA approved plants for acquisition both in India and abroad to minimise the losses it incurred due to the imposition of ban on its 30 generic medicines by the US drug regulator.
"We are looking for everything possible; the US market is very important for us and we will do everything to get there as soon as possible," Ranbaxy CEO Malvinder Mohan Singh told reporters here.
The company is looking to shift manufacturing of some of these banned drugs to other FDA plants in India and in US both.
The company is looking to acquire FDA aproved manufacturing facilites overses as soon as possible.
"We are actively looking for acquisitions ...
- Ranbaxy scouting for USFDA approved plants for acquisition.
- News wire article from: PTI - The Press Trust of India Ltd. October 31, 2008 700+ words
Ranbaxy scouting for USFDA approved plants for acquisition New Delhi, Oct 31 (PTI) Pharma company Ranbaxy Laboratory is looking for USFDA approved plants for acquisition both in India and abroad to minimise...
- BRIEFING - ASIA HEALTH - NOV 3, 2008.
- News wire article from: AsiaPulse News November 3, 2008 700+ words
...official at MSD Korea Ltd. RANBAXY SCOUTING FOR USFDA APPROVED PLANTS FOR ACQUISITION NEW DELHI - Pharmaceuticals company Ranbaxy Laboratory (BSE:500359) is looking for USFDA approved plants for acquisition both in India and abroad to minimise...
- After BPO, pharma faces US backlash.
- Newspaper article from: Economic Times (New Delhi, India) June 26, 2007 700+ words
...agency does not conduct frequent inspections of FDA-approved plants in India and this is a matter of concern. The Indian...small companies are involved in counterfeiting and USFDA approved plants in India are not as frequently inspected as they...
- Sweet 'n' not-so-sweet pills kept pharma sector in good health.
- News wire article from: PTI - The Press Trust of India Ltd. December 24, 2008 700+ words
...the noose around its neck. The American health regulator banned import of 30 drugs produced in Ranbaxy's two USFDA approved plants located in Dewas and Poanta Sahib. On the whole, it was a year when the pharmaceutical industry players had...
- Ranbaxy may not meet growth guidelines: Malvinder Singh.
- News wire article from: PTI - The Press Trust of India Ltd. November 2, 2008 700+ words
...inventory due to a ban imposed on import of 30 generic drugs produced at its two US Food and Drug Administration (USFDA) approved plants at Poanta Sahib (Himachal Pradesh) and Dewas (Madhya Pradesh). It had affected sales in the US, which is...
- Ventiv Health Announces Multi-Year Agreement With Lupin Pharmaceuticals, Inc.
- Press release article from: PR Newswire March 15, 2004 700+ words
...infections, cardiovascular disease and tuberculosis. Lupin's portfolio of drugs, manufactured in global-scale USFDA approved plants, also includes NSAIDS (non-steroidal anti-inflammatory drugs), COX-2 inhibitors and herbal- based phytomedicines...
- Set up panel for curbing fake medicines: Assocham.
- News wire article from: PTI - The Press Trust of India Ltd. October 17, 2007 700+ words
...products from India, the chamber said. It is very unfortunate that despite that the country has highest number of USFDA approved plants outside US, the latter's administration has kept India under 301 watch list to monitor its pharma exports...
- Biocon launches pre-filled safety syringe.
- News wire article from: PTI - The Press Trust of India Ltd. June 4, 2008 700+ words
...syringe is immense as India is being viewed as a low cost-high quality man base. It has the largest number of USFDA approved plants outside US. The company plans to launch these two new products outside India. The company has an exclusive tie...